MIStar
Apollo Medical Imaging Technology is a clinically-driven medical imaging software company specializing in the creation of advanced image processing software for clinical and research applications. Their flagship product, MIStar, is a fast, economical, and easy-to-use software package that provides a broad spectrum of advanced functions and cost-effective cross-modality solutions for clinicians and the OEMs that serve them. MIStar supports various imaging modalities, including CT, MR, NM, and PET, and offers advanced modules such as CT Perfusion for stroke, brain tumor, body tumor, liver, kidney, and prostate; DSC-MRI for stroke; DCE-MRI for brain tumor, breast, body tumor, liver, kidney, and prostate; DWI & ADC; DTI Fiber Tractography; NM Renogram Analysis; and Image Fusion. The software features data access and image input through DICOM networking functions, an intuitive clinical database, and easy anonymization and archiving.
Learn more
Aidoc
Aidoc develops advanced healthcare-grade AI based decision support software. Our technology analyzes medical imaging to provide one of the most comprehensive solutions for flagging acute abnormalities across the body, helping radiologists prioritize life threatening cases and expedite patient care. Empowering radiologists to detect urgent cases faster and reducing overall report turnaround time directly in the workflow. 510(k) Triage and notification software indicated for use in the analysis of non-enhanced head CT images; flags and communicates suspected positive findings of pathologies in head CT images, namely Intracranial Hemorrhage (ICH). 510(k) triage and notification software indicated for use in the analysis of Head CTA images; flags and communicates Brain Aneurysm (BA). 510(k) triage and notification software indicated for use in the analysis of Chest X-Ray images; flags and communicates Pneumothorax (Ptx).
Learn more
Elements Contrast Clearance Analysis
Brainlab's Elements Contrast Clearance Analysis is an MRI-based methodology designed to differentiate regions of contrast clearance and accumulation in brain tumor datasets. This high-resolution analysis provides additional insights to support ongoing assessment and decision-making in clinical specialties such as radiosurgery, radiation oncology, neurosurgery, neuro-oncology, and neuroradiology. The process involves acquiring two standard 3D T1-weighted MRIs, one approximately 5 minutes and another 60 to 105 minutes after the injection of a standard dose of contrast agent. The first series is subtracted from the second to generate volumetric maps that distinguish regions of contrast clearance (depicted in blue) from contrast accumulation (depicted in red). These results enable clinicians to assess radiation effects versus tumor regrowth, facilitating more informed decisions for initial and follow-up treatments.
Learn more
BrainSightAI
BrainSightAI is a health tech company leveraging artificial intelligence and machine learning to revolutionize brain mapping through AI-based connectomics, generating personalized brain maps. Our VoxelBox products utilize AI-based connectomics to generate personalized brain maps. These tools aim to enhance pre-surgical planning and improve outcomes for patients with brain tumors and other neurological conditions. BrainSightAI collaborates with leading hospitals nationwide to conduct clinical trials focused on various brain-based disorders, including Alzheimer's disease, brain tumors, psychiatric disorders, Parkinson's disease, and stroke. Our mission is to advance brain science and enhance lives by providing cutting-edge tools for understanding the human brain.
Learn more